Chemoinformaics analysis of BENZYLADENINE-3-O-BETA-D-GLUCOSIDE
Molecular Weight | 387.396 | nRot | 5 |
Heavy Atom Molecular Weight | 366.228 | nRig | 23 |
Exact Molecular Weight | 387.154 | nRing | 4 |
Solubility: LogS | -2.76 | nHRing | 3 |
Solubility: LogP | -0.177 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 5 | No. of Arom Atom | 15 |
No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
nHA | 10 | APOL | 53.5727 |
nHD | 5 | BPOL | 28.5033 |
QED | 0.379 |
Synth | 4.128 |
Natural Product Likeliness | 0.867 |
NR-PPAR-gamma | 0.04 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.747 |
HIA | 0.988 |
CACO-2 | -5.548 |
MDCK | 0.00000524 |
BBB | 0.743 |
PPB | 0.262332 |
VDSS | 2.621 |
FU | 0.639908 |
CYP1A2-inh | 0.028 |
CYP1A2-sub | 0.131 |
CYP2c19-inh | 0.017 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.31 |
CYP2d6-inh | 0.066 |
CYP2d6-sub | 0.046 |
CYP3a4-inh | 0.06 |
CYP3a4-sub | 0.107 |
CL | 8.96 |
T12 | 0.689 |
hERG | 0.049 |
Ames | 0.082 |
ROA | 0.456 |
SkinSen | 0.084 |
Carcinogencity | 0.039 |
EI | 0.007 |
Respiratory | 0.858 |
NR-Aromatase | 0.926 |
Antiviral | Yes |
Prediction | 0.89733 |